| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Revenue | $2.17B | +34.1% |
| Cost of Revenue | $477.1M | +31.5% |
| Gross Profit | $1.69B | +34.8% |
| R&D Expense | $499.8M | +42.9% |
| SG&A Expense | $212.1M | +19.4% |
| Operating Income | -$121.5M | +48.2% |
| Interest Expense | $5.3M | -18.2% |
| Pre-tax Income | -$29.2M | +84.0% |
| Income Tax | $28.5M |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.42B | +12.7% |
| Accounts Receivable | $736.5M | +26.4% |
| Current Assets | $3.40B | +17.5% |
| Total Assets | $4.70B | +30.4% |
| Current Liabilities | $3.11B | +102.7% |
| Long-term Debt | $1.14B | +0.7% |
| Total Liabilities | $3.43B | +19.0% |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $779.8M | +68.7% |
| Capital Expenditures | $144.6M | +48.8% |
| Investing Cash Flow | -$683.2M | -163.4% |
| Financing Cash Flow | $64.2M | +39.6% |
| Free Cash Flow | $635.3M | +74.0% |
| +44.0% |
| Net Income | -$57.7M | +71.5% |
| EPS (Basic) | -$0.39 | +72.1% |
| EPS (Diluted) | -$0.39 | +72.1% |
| Stockholders' Equity |
| $1.27B |
| +75.7% |